Top

Cancer Immunology, Immunotherapy

Published in:

01-06-2000 | ORIGINAL ARTICLE

Single-chain antibodies against human insulin-like growth factor I receptor: expression, purification, and effect on tumor growth

Authors: Shu-Lian Li, Shu-Jian Liang, Ning Guo, Anna M. Wu, Yoko Fujita-Yamaguchi

Published in: Cancer Immunology, Immunotherapy | Issue 4-5/2000

Title: Single-chain antibodies against human insulin-like growth factor I receptor: expression, purification, and effect on tumor growth
Authors: Shu-Lian Li
Shu-Jian Liang
Ning Guo
Anna M. Wu
Yoko Fujita-Yamaguchi
Publication date: 01-06-2000
Publisher: Springer-Verlag
Published in: Cancer Immunology, Immunotherapy / Issue 4-5/2000
Print ISSN: 0340-7004
Electronic ISSN: 1432-0851
DOI: https://doi.org/10.1007/s002620000115

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 4-5/2000

Pharmacokinetics and biodistribution of a light-chain-shuffled CC49 single-chain Fv antibody construct

Immunological properties of a single-chain fragment of the anti-idiotypic antibody ACA125

Noscapine inhibits tumor growth with little toxicity to normal tissues or inhibition of immune responses

The immunological effects of taxanes

Functional assessment in vitro of human-complement-dependent antibody-induced cytotoxicity of neoplastic cells

Inhibition of tumor growth by poly(ethylene glycol) derivatives of anti-ErbB2 antibodies

Keynote webinar | Spotlight on antibody–drug conjugates in cancer